Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6631 AL 6645

Implication of Covid-19 on Neurological Complications with Specific Emphasis on Alzheimer's and Parkinson's Disease

Sood A, Goyal R, Singh H, Behl T, Arora S, Saini B, Kaur R.

CNS Neurol Disord Drug Targets. 2022;21(3):235-245. doi: 10.2174/1871527320666210820092817.

Squalamine and trodusquemine: two natural products for neurodegenerative diseases, from physical chemistry to the clinic

Limbocker R, Errico S, Barbut D, Knowles TPJ, Vendruscolo M, Chiti F, Zasloff M.

Nat Prod Rep. 2022 Apr 20;39(4):742-753. doi: 10.1039/d1np00042j.

Current Research on Pro-drug Therapies for Parkinson's and Alzheimer's Disease

Huo C, Wu L, Jiang Z, Yang J, Wang Z, Li Y, Qian S.

Med Chem. 2022;18(6):655-666. doi: 10.2174/1573406418666211130150821.

Challenges of repurposing tetracyclines for the treatment of Alzheimer's and Parkinson's disease

Markulin I, Matasin M, Turk VE, Salković-Petrisic M.

J Neural Transm (Vienna). 2022 Jun;129(5-6):773-804. doi: 10.1007/s00702-021-02457-2. Epub 2022 Jan 4.

Neurobiological Promises of the Bitter Diterpene Lactone Andrographolide

Hossain R, Quispe C, Herrera-Bravo J, Beltrán JF, Islam MT, Shaheen S, Cruz-Martins N, Martorell M, Kumar M, Sharifi-Rad J, Ozdemir FA, Setzer WN, Alshehri MM, Calina D, Cho WC.

Oxid Med Cell Longev. 2022 Feb 1;2022:3079577. doi: 10.1155/2022/3079577. eCollection 2022.

Electroacupuncture ameliorates neuroinflammation in animal models

Xin YY, Wang JX, Xu AJ.

Acupunct Med. 2022 Oct;40(5):474-483. doi: 10.1177/09645284221076515. Epub 2022 Mar 1.

Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer's disease

Zhou X, Venigalla M, Raju R, Münch G.

J Neural Transm (Vienna). 2022 Jun;129(5-6):755-771. doi: 10.1007/s00702-022-02480-x. Epub 2022 Mar 16.

A Review on the Arylpiperazine Derivatives as Potential Therapeutics for the Treatment of Various Neurological Disorders

Kumar B, Kumar N, Thakur A, Kumar V, Kumar R, Kumar V.

Curr Drug Targets. 2022;23(7):729-751. doi: 10.2174/1389450123666220117104038.

Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics

Roy B, Lee E, Li T, Rampersaud M.

Genes (Basel). 2022 Feb 25;13(3):425. doi: 10.3390/genes13030425.

Repetitive transcranial magnetic stimulation (rTMS) for multiple neurological conditions in rodent animal models: A systematic review

Zong X, Gu J, Geng D, Gao D.

Neurochem Int. 2022 Jul;157:105356. doi: 10.1016/j.neuint.2022.105356. Epub 2022 May 2.

Pathophysiological Role and Medicinal Chemistry of A(2A) Adenosine Receptor Antagonists in Alzheimer's Disease

Merighi S, Borea PA, Varani K, Vincenzi F, Travagli A, Nigro M, Pasquini S, Suresh RR, Kim SW, Volkow ND, Jacobson KA, Gessi S.

Molecules. 2022 Apr 21;27(9):2680. doi: 10.3390/molecules27092680.

Unmet needs in the diagnosis and treatment of Parkinson's disease psychosis and dementia-related psychosis

Sabbagh M, Small GW, Isaacson SH, Torres-Yaghi Y, Pagan F, Pahwa R.

Int J Psychiatry Clin Pract. 2023 Mar;27(1):69-81. doi: 10.1080/13651501.2022.2058406. Epub 2022 May 14.

Applications of Gold Nanoparticles in Brain Diseases across the Blood-Brain Barrier

Zhang J, Yang T, Huang W, Yu Y, Sun T.

Curr Med Chem. 2022;29(39):6063-6083. doi: 10.2174/0929867329666220527121943.

Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review

Mahapatra MK, Karuppasamy M, Sahoo BM.

Pharm Res. 2022 Jun;39(6):1233-1248. doi: 10.1007/s11095-022-03302-1. Epub 2022 Jun 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias